April 14 (Reuters) - NKGen Biotech Inc will go public in
the United States via a merger with special purpose acquisition
company Graf Acquisition Corp IV , the companies said
in a statement on Friday.
(Reporting by Chandni Shah in Bengaluru; Editing by Sandra
Maler)
Disclaimer: The views expressed in this article are those of the author and may not reflect those of Kitco Metals Inc. The author has made every effort to ensure accuracy of information provided; however, neither Kitco Metals Inc. nor the author can guarantee such accuracy. This article is strictly for informational purposes only. It is not a solicitation to make any exchange in commodities, securities or other financial instruments. Kitco Metals Inc. and the author of this article do not accept culpability for losses and/ or damages arising from the use of this publication.